Rocket Pharmaceuticals (RCKTW) Competitors $0.02 0.00 (-3.85%) (As of 01:23 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsFinancialsHeadlinesSEC FilingsTrends RCKTW vs. ATNFW, LBPSW, AEHAW, AIMDW, ALVOW, ALVO, ACABW, ACABU, BFRIW, and BTMDWShould you be buying Rocket Pharmaceuticals stock or one of its competitors? The main competitors of Rocket Pharmaceuticals include 180 Life Sciences (ATNFW), 4D pharma (LBPSW), Aesther Healthcare Acquisition (AEHAW), Ainos (AIMDW), Alvotech (ALVOW), Alvotech (ALVO), Atlantic Coastal Acquisition Corp. II (ACABW), Atlantic Coastal Acquisition Corp. II (ACABU), Biofrontera (BFRIW), and biote (BTMDW). These companies are all part of the "pharmaceutical products" industry. Rocket Pharmaceuticals vs. 180 Life Sciences 4D pharma Aesther Healthcare Acquisition Ainos Alvotech Alvotech Atlantic Coastal Acquisition Corp. II Atlantic Coastal Acquisition Corp. II Biofrontera biote Rocket Pharmaceuticals (NASDAQ:RCKTW) and 180 Life Sciences (NASDAQ:ATNFW) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their community ranking, profitability, analyst recommendations, earnings, dividends, risk, institutional ownership, media sentiment and valuation. Which has preferable valuation and earnings, RCKTW or ATNFW? CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioRocket PharmaceuticalsN/AN/AN/AN/AN/A180 Life SciencesN/AN/AN/AN/AN/A Does the MarketBeat Community prefer RCKTW or ATNFW? Rocket Pharmaceuticals and 180 Life Sciences both received 0 outperform votes by MarketBeat users. CompanyUnderperformOutperformRocket PharmaceuticalsN/AN/A180 Life SciencesN/AN/A Does the media prefer RCKTW or ATNFW? In the previous week, Rocket Pharmaceuticals had 4 more articles in the media than 180 Life Sciences. MarketBeat recorded 4 mentions for Rocket Pharmaceuticals and 0 mentions for 180 Life Sciences. Rocket Pharmaceuticals' average media sentiment score of 0.35 beat 180 Life Sciences' score of 0.00 indicating that Rocket Pharmaceuticals is being referred to more favorably in the media. Company Overall Sentiment Rocket Pharmaceuticals Neutral 180 Life Sciences Neutral Is RCKTW or ATNFW more profitable? Company Net Margins Return on Equity Return on Assets Rocket PharmaceuticalsN/A N/A N/A 180 Life Sciences N/A N/A N/A SummaryRocket Pharmaceuticals beats 180 Life Sciences on 2 of the 2 factors compared between the two stocks. Ad Crypto Swap ProfitsURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.>> Register for the Workshop Now Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKTW and its competitors with MarketBeat's FREE daily newsletter. Email Address Media Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart RCKTW vs. The Competition Export to ExcelMetricRocket PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket CapN/A$202.11M$5.13B$9.28BDividend YieldN/A3.54%4.81%4.06%P/E RatioN/A316.48135.2417.51Price / SalesN/A15,204.511,174.53134.92Price / CashN/A11.6740.4837.95Price / BookN/A7.264.884.94Net IncomeN/A-$18.52M$118.56M$225.30M7 Day PerformanceN/A181.94%14.97%-1.11%1 Month PerformanceN/A131.30%15.07%7.29%1 Year PerformanceN/A112.50%34.31%23.06% Rocket Pharmaceuticals Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)RCKTWRocket PharmaceuticalsN/A$0.03-3.8%N/A-93.3%$0.00N/A0.00240Gap UpHigh Trading VolumeATNFW180 Life SciencesN/A$0.01-8.5%N/A+41.0%$0.00N/A0.007Positive NewsGap DownLBPSW4D pharmaN/A$0.04-25.7%N/AN/A$0.00$522,000.000.00N/AGap DownAEHAWAesther Healthcare AcquisitionN/A$0.16+6.2%N/A+4.1%$0.00N/A0.002Gap UpAIMDWAinosN/A$0.03-42.9%N/AN/A$0.00$40,633.000.0040Positive NewsALVOWAlvotechN/A$2.78+1.1%N/A+12.9%$0.00$391.87M0.004Gap UpALVOAlvotech2.7799 of 5 stars$12.06+2.2%$18.00+49.3%+13.9%$0.00$93.38M0.001,026ACABWAtlantic Coastal Acquisition Corp. IIN/A$0.06+50.0%N/AN/A$0.00N/A0.004High Trading VolumeACABUAtlantic Coastal Acquisition Corp. IIN/A$8.05-26.8%N/AN/A$0.00N/A0.004Gap DownBFRIWBiofronteraN/A$0.09-0.1%N/A+263.0%$0.00$35.36M0.0070Positive NewsBTMDWbioteN/A$0.47flatN/AN/A$0.00$193.06M0.00N/A Related Companies and Tools Related Companies ATNFW Alternatives LBPSW Alternatives AEHAW Alternatives AIMDW Alternatives ALVOW Alternatives ALVO Alternatives ACABW Alternatives ACABU Alternatives BFRIW Alternatives BTMDW Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:RCKTW) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredTop Picks for Trump’s Pro-Crypto AmericaCoins Set to Soar with a Pro-Crypto White House President-Elect Donald Trump is reported to be holding over...Crypto 101 Media | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | SponsoredBitcoin is going to $100,000 … before Inauguration DayMark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredPlease don’t take this warning lightly…Something huge is about to hit the stock market. Wall St. legend Louis Navellier calls it: "The most signif...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.